The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -41.51%. However, over the last six months, the performance has been stronger by -29.80%. The price of TNDM decreased -29.89% over the last 30 days. And in the last five days, it has fallen by -11.24%.
Tandem Diabetes Care Inc. (TNDM) stock is currently valued at $26.29. During the last session, the stock experienced a remarkable rise, reaching $27.89 after opening at $27.85. The stock briefly dropped to $26.105 before ultimately closing at $28.18.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Tandem Diabetes Care Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $75.47 on 05/31/22, while the lowest value for the same period was recorded at $28.02 on 05/25/23.
52-week price history of TNDM Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Tandem Diabetes Care Inc.’s current trading price is -65.16% away from its 52-week high, while its distance from the 52-week low is -6.17%. The stock’s price range during this time has been between $28.02 and $75.47. The trading volume for the Healthcare sector company’s shares reached about 1.2 million for the day, which was lower than the average daily volume of 1.34 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Tandem Diabetes Care Inc. (TNDM) has experienced a quarterly decline of -27.75% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.79B and boasts a workforce of 2600 employees.
Tandem Diabetes Care Inc.: Analysts’ Ratings Unveiled
As of right now, 8 analysts are rating Tandem Diabetes Care Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 8 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 39.44, with a change in price of -18.66. Similarly, Tandem Diabetes Care Inc. recorded 1,225,047 in trading volume during the last 100 days, posting a change of -41.51%.
TNDM’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNDM stands at 0.84. Similarly, the long-term debt-to-equity ratio is also 0.84.
TNDM Stock Stochastic Average
Today’s raw stochastic average for Tandem Diabetes Care Inc. over the last 50 days is 1.03%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 1.26%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 4.46% and 6.95%, respectively.
